Prostate cancer-associated urinary proteomes differ before and after prostatectomy
Background: A wide range of disorders can be detected in the urine. Tumor-modifying proteins in the urine may serve as a diagnostic tool for cancer patients and the alterations in their profiles may indicate efficacies of chemotherapy, radiotherapy, and surgery. Methods: We focused on urinary proteo...
Main Authors: | Yan Feng, Shengzhi Liu, Rongrong Zha, Xun Sun, Kexin Li, Di Wu, Uma K. Aryal, Michael Koch, Bai-Yan Li, Hiroki Yokota |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-10-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359221131532 |
Similar Items
-
PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9
by: Xun Sun, et al.
Published: (2022-09-01) -
Mechanical Loading-Driven Tumor Suppression Is Mediated by Lrp5-Dependent and Independent Mechanisms
by: Yan Feng, et al.
Published: (2021-01-01) -
Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium
by: Tomohiko Sano, et al.
Published: (2021-03-01) -
Urinary infection before and after prostatectomy
by: Pourmand Gholamreza, et al.
Published: (2010-01-01) -
Unveiling the Dichotomy of Urinary Proteins: Diagnostic Insights into Breast and Prostate Cancer and Their Roles
by: Yan Feng, et al.
Published: (2023-12-01)